Document Detail

Consequences of not treating children with laron syndrome (primary growth hormone insensitivity).
MedLine Citation:
PMID:  11964019     Owner:  NLM     Status:  MEDLINE    
The follow-up of a large cohort of patients with Laron syndrome (LS) from infancy to adult age has enabled us to determine the effects of long-term insulin-like growth factor-I (IGF-I) deficiency on auxological, biochemical, physiological and psychological parameters. We found that early and continuous IGF-I deficiency (the anabolic effector of growth hormone) causes dwarfism, acromicria, organomicria, marked obesity, insulin resistance, retardation of skeletal maturation and osteoporosis, as well as muscular and central nervous tissue underdevelopment, and a series of biochemical changes including hypercholesterolemia. These multiple pathologies impair the quality of life of these patients. It is concluded that patients with LS need IGF-I replacement treatment throughout life.
Z Laron
Related Documents :
12921699 - Insulin-like growth factor binding proteins in follicular fluid from morphologically di...
3311719 - Modulation of aromatase and p450 cholesterol side-chain cleavage enzyme activities of h...
6389319 - Cultured hepatoma cells for the study of enzyme regulation: induction of ornithine deca...
3056519 - Determinants of growth-promoting activity reside in the a-domain of insulin-like growth...
8655449 - Effects of insulin-like growth factor i and insulin on proliferation and on basal and l...
8187319 - The effects of recombinant human insulin-like growth factor i on growth hormone secreti...
21060309 - Vitamin d status and metabolic syndrome in asian indians.
3549779 - Insulin stimulates volume absorption in the rabbit proximal convoluted tubule.
6315349 - Effects of forskolin on insulin release and cyclic amp content in rat pancreatic islets.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of pediatric endocrinology & metabolism : JPEM     Volume:  14 Suppl 5     ISSN:  0334-018X     ISO Abbreviation:  J. Pediatr. Endocrinol. Metab.     Publication Date:  2001  
Date Detail:
Created Date:  2002-04-19     Completed Date:  2002-05-24     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9508900     Medline TA:  J Pediatr Endocrinol Metab     Country:  England    
Other Details:
Languages:  eng     Pagination:  1243-8; discussion 1261-2     Citation Subset:  IM    
Endocrinology and Diabetes Research Unit, Schneider Children's Medical Center, Tel Aviv University, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Child, Preschool
Cohort Studies
Disease Progression
Follow-Up Studies
Growth Disorders / etiology*,  pathology,  physiopathology,  psychology,  therapy
Human Growth Hormone / physiology*
Insulin-Like Growth Factor I / deficiency,  therapeutic use
Reg. No./Substance:
12629-01-5/Human Growth Hormone; 67763-96-6/Insulin-Like Growth Factor I

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Growth hormone deficiency in the transition adolescent: should treatment be continued in adult life?
Next Document:  Quality of life and retrospective perception of the effect of growth hormone treatment in adult pati...